SYNSORB Biotech Inc., will host a dial-in conference call with David J. Cox, Ph.D., President and Chief Executive officer, John Frey, Ph.D. Vice President Clinical and Regulatory Affairs and Cindy Gray, Investor Relations on Monday, July 17, 2000 at 4:15 PM EST.
The call will focus on the Company's recent announcement pertaining to the interim analysis of the SYNSORB Pk(R) Phase III trial, and the clinical and regulatory plans going forward.
The call number is: United States/Canada: 1-800-230-1074
International: 1-612-332-0107
A replay of the conference call will be available from Monday, July
17, 2000 at 8:15 PM EST until Friday, July 21, 2000 11:59 PM EST.
The replay number is: United States/Canada: 1-800-475-6701
International: 1-320-365-3844
Access code: 529300
++++++++++++++++++ ALSO +++++++++++++++++++++++++++++
SmallCaps Online LLC announced today(7/18) that it has issued an update on SYNSORB Biotech Inc. (NASDAQ:SYBB) (TSE:SYB) commenting on recent clinical news and has reiterated its BUY recommendation on current weakness. The full text of the report can be accessed at SmallCaps Online's web site, at www.SmallCapsOnline.com. |
